tradingkey.logo
tradingkey.logo
Search

Integra Lifesciences Holdings Corp

IART
Add to Watchlist
16.650USD
-0.470-2.75%
Close 07-31 16:00ETQuotes delayed by 15 min
1.29BMarket Cap
LossP/E TTM

IART Financials

See Integra Lifesciences Holdings Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Integra Lifesciences Holdings Corp Earnings Date

Latest Release
Jul 29, 2026
EPS / Forecast
0.06/0.48
Revenue / Forecast
418.76M/418.65M
Period
FY2025 Earnings
Revenue(YoY)
1.64B
1.53%
EPS(YoY)
-6.74
-7370.50%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
100.92%0.06
81.86%-0.06
-108.73%-0.02
49.67%-0.07
-3839.62%-6.31
-683.68%-0.33
-0.25%0.25
-157.18%-0.14
-410.00%-0.16
-114.26%-0.04
-59.99%0.25
--0.24
--0.05
--0.30
--0.64
----
----
----
----
----
Revenue
0.76%418.76M
2.42%391.92M
-1.74%434.93M
5.57%402.06M
-0.61%415.61M
3.74%382.65M
11.49%442.65M
-0.41%380.83M
9.68%418.18M
-3.14%368.87M
-0.25%397.04M
-0.72%382.42M
-4.16%381.27M
1.12%380.85M
-1.85%398.02M
-0.43%385.19M
2.01%397.81M
4.60%376.64M
4.34%405.52M
4.49%386.86M
Net Profit
100.93%4.48M
81.75%-4.62M
-108.77%-1.70M
49.47%-5.40M
-3803.18%-484.07M
-670.89%-25.29M
-2.01%19.43M
-154.85%-10.70M
-396.41%-12.40M
-113.54%-3.28M
-62.54%19.83M
-60.94%19.50M
-90.66%4.18M
-26.37%24.23M
16.66%52.95M
15.47%49.91M
27.72%44.79M
-27.52%32.90M
-51.07%45.38M
33.68%43.23M
Net Margin
100.92%1.07%
82.18%-1.18%
-108.92%-0.39%
52.14%-1.34%
-3827.33%-116.47%
-643.13%-6.61%
-12.11%4.39%
-155.08%-2.81%
-370.25%-2.97%
-113.98%-0.89%
-62.45%5.00%
--5.10%
--1.10%
--6.36%
--13.30%
----
----
----
----
----
Gross Margin
1.21%54.90%
3.49%57.18%
-3.72%57.02%
-0.05%56.24%
-8.19%54.24%
-6.01%55.26%
-0.46%59.22%
-14.26%56.27%
-5.01%59.08%
-5.06%58.79%
-3.12%59.49%
--65.62%
--62.20%
--61.92%
--61.40%
----
----
----
----
----
Debt to assets ratio
4.72%52.54%
14.64%52.14%
15.38%51.53%
13.01%50.22%
12.00%50.17%
-0.06%45.48%
12.63%44.66%
10.40%44.43%
18.42%44.80%
18.30%45.51%
6.86%39.65%
--40.25%
--37.83%
--38.47%
--37.11%
----
----
----
----
----
Revenue
0.76%418.76M
2.42%391.92M
-1.74%434.93M
5.57%402.06M
-0.61%415.61M
3.74%382.65M
11.49%442.65M
-0.41%380.83M
9.68%418.18M
-3.14%368.87M
-0.25%397.04M
-0.72%382.42M
-4.16%381.27M
1.12%380.85M
-1.85%398.02M
-0.43%385.19M
2.01%397.81M
4.60%376.64M
4.34%405.52M
4.49%386.86M
Operating profit
23.35%41.29M
42.21%37.94M
27.47%85.90M
55.40%40.29M
-30.22%33.47M
-35.46%26.68M
-3.74%67.39M
-68.45%25.93M
-17.57%47.97M
-32.67%41.34M
-12.70%70.01M
8.33%82.17M
-20.49%58.20M
-3.86%61.40M
7.34%80.20M
2.23%75.85M
2.73%73.20M
10.29%63.86M
-2.51%74.72M
2.43%74.20M
Net Profit
100.93%4.48M
81.75%-4.62M
-108.77%-1.70M
49.47%-5.40M
-3803.18%-484.07M
-670.89%-25.29M
-2.01%19.43M
-154.85%-10.70M
-396.41%-12.40M
-113.54%-3.28M
-62.54%19.83M
-60.94%19.50M
-90.66%4.18M
-26.37%24.23M
16.66%52.95M
15.47%49.91M
27.72%44.79M
-27.52%32.90M
-51.07%45.38M
33.68%43.23M
Current assets
4.26%1.19B
5.85%1.17B
7.20%1.16B
4.01%1.14B
2.75%1.14B
-21.79%1.11B
2.23%1.08B
7.04%1.10B
5.81%1.11B
37.51%1.42B
-8.91%1.06B
-14.14%1.03B
-7.57%1.05B
-3.43%1.03B
0.67%1.16B
8.40%1.20B
10.17%1.14B
2.60%1.07B
-6.75%1.15B
-4.19%1.10B
Total current liabilities
-64.41%330.88M
-62.24%346.85M
-50.55%455.98M
-60.11%364.05M
183.20%929.81M
203.73%918.45M
200.39%922.13M
156.55%912.56M
-13.03%328.32M
7.12%302.39M
-4.34%306.98M
16.84%355.71M
27.71%377.50M
-10.62%282.29M
-5.62%320.91M
-8.53%304.45M
-7.27%295.60M
-23.40%315.83M
-15.21%340.02M
30.46%332.86M
Total assets
-2.85%3.56B
-11.72%3.58B
-10.78%3.60B
-10.31%3.65B
-9.98%3.67B
-0.62%4.05B
6.75%4.04B
8.73%4.07B
7.86%4.07B
8.97%4.08B
-2.77%3.78B
-1.78%3.74B
0.66%3.78B
1.92%3.74B
2.84%3.89B
0.86%3.81B
1.08%3.75B
-1.86%3.67B
4.63%3.78B
9.29%3.77B
Total liabilities
-4.15%2.52B
0.27%2.54B
2.66%2.56B
2.54%2.61B
3.50%2.63B
1.95%2.53B
13.58%2.49B
17.78%2.54B
21.29%2.54B
19.97%2.48B
5.21%2.19B
3.72%2.16B
0.12%2.09B
0.52%2.07B
-0.58%2.09B
-2.81%2.08B
-2.15%2.09B
-7.03%2.06B
-0.13%2.10B
4.24%2.14B
Total equity
0.45%1.04B
-31.61%1.04B
-32.47%1.04B
-31.81%1.04B
-32.30%1.04B
-4.62%1.52B
-2.68%1.55B
-3.65%1.52B
-8.85%1.53B
-4.60%1.60B
-12.00%1.59B
-8.42%1.58B
1.34%1.68B
3.70%1.67B
7.10%1.80B
5.68%1.72B
5.46%1.66B
5.61%1.62B
11.22%1.68B
16.72%1.63B
Net operating income
155.66%22.80M
187.08%9.80M
-76.71%11.82M
81.93%40.91M
-77.92%8.92M
-171.45%-11.26M
-13.63%50.74M
-16.01%22.48M
42.87%40.40M
-39.76%15.76M
-31.15%58.75M
-60.81%26.77M
-57.46%28.28M
-41.02%26.16M
23.18%85.33M
-17.48%68.31M
-27.18%66.48M
-35.81%44.34M
-13.69%69.28M
18.87%82.78M
Net investment
-99.94%-43.28M
58.66%-14.85M
-721.53%-34.91M
-49.94%-15.59M
93.28%-21.65M
33.44%-35.92M
92.58%-4.25M
-35.07%-10.40M
-1972.28%-322.20M
-293.79%-53.97M
-4.39%-57.23M
-151.99%-7.70M
-245.66%-15.55M
2.58%-13.70M
-99.45%-54.82M
274.69%14.80M
43.19%-4.50M
88.03%-14.07M
23.48%-27.48M
-26.15%-8.47M
Net financing
96.13%-818.00K
-76.55%8.30M
440.45%24.34M
48.56%-10.24M
77.45%-21.14M
-90.14%35.38M
-3.77%-7.15M
59.90%-19.91M
-776.72%-93.75M
320.48%358.68M
92.95%-6.89M
-549.82%-49.66M
18.67%-10.69M
-21.89%-162.68M
-18852.21%-97.70M
-538.44%-7.64M
86.51%-13.15M
-4326.70%-133.47M
-97.55%521.00K
105.27%1.74M

FAQs

What is the total revenue of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its total revenue reached 1.64B, with a year-on-year change of 1.61B.

What are the current assets of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its current assets were 1.16B, with a year-on-year change of 7.20.

What are the total assets of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its total assets of Integra Lifesciences Holdings Corp were 3.60B, with a year-on-year change of -10.78.

What are the total liabilities of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its total liabilities of Integra Lifesciences Holdings Corp were 2.56B, with a year-on-year change of 2.66.

What is the total equity of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its total equity of Integra Lifesciences Holdings Corp was 1.04B, with a year-on-year change of -32.47.

What is the net operating income of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its net operating income of Integra Lifesciences Holdings Corp was 186.35M, with a year-on-year change of 2.04.

What is the net investment of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its net investment of Integra Lifesciences Holdings Corp was -108.06M, with a year-on-year change of 72.35.

What is the net financing of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its net financing of Integra Lifesciences Holdings Corp was 28.34M, with a year-on-year change of -88.09.

What is the Earnings Per Share (EPS) of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -6.74, with a year-on-year change of -7370.50.

What is the net income of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its net income was -516.47M, with a year-on-year change of -7337.70.

What is the net margin of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its net profit margin was -31.58, with a year-on-year change of -7225.33.

What is the gross margin of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its gross margin was 55.71, with a year-on-year change of -4.59.

What is the debt-to-asset ratio of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its debt-to-asset ratio was 51.53, with a year-on-year change of 15.38.

What is the Return on Equity (ROE) of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its Return on Equity (ROE) was -39.90, with a year-on-year change of -8901.87.

What is the Return on Assets (ROA) of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its Return on Assets (ROA) was -13.52, with a year-on-year change of -7512.94.

What is the operating profit of Integra Lifesciences Holdings Corp?

According to Integra Lifesciences Holdings Corp's FY2025 earnings report, its operating profit was 186.35M, with a year-on-year change of 2.04.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.